Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia.

ABSTRACT:

SUBMITTER: Goemans BF 

PROVIDER: S-EPMC8324475 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature